来源:药渡撰文:Pharmadeep编辑:活力哈哈2025年3月25日,康希诺生物(688185.SH)与沙特阿拉伯医药企业SPIMACO签署合作协议,双方将共同推动四价流脑结合疫苗曼海欣®(MCV4)在中东及北非(MENA)市场的准入,并合作建设本地化生产体系。此次合作不仅是康希诺国际化布局的重要一步,也标志着中国生物医药企业从单一产品出口向技术合作与区域生态共建的转型。图片来源:康希诺生物...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.